重症监护室肺脓肿的流行病学与临床模式:法国多中心回顾性研究
该法国多中心回顾性观察研究基于ICD-10编码,纳入2015至2022年171例ICU肺脓肿患者,旨在描述临床微生物特征、ICU管理及ICU死亡危险因素。结果显示40.9%免疫抑制、38%为医院获得性感染,最常见病原为肠杆菌科31%、金黄色葡萄球菌22%、铜绿假单胞菌19.3%,真菌10.5%。多因素回归显示年龄(OR 1.05,P=.007)、ICU期间肾替代治疗(OR 3.56,P=.019)、真菌感染(OR 9.12,P=.0006)为独立死亡预测因素,引流或手术不是。作者认为需前瞻性研究聚焦一线抗菌治疗和感染源控制以标准化管理。
要点
- ICU肺脓肿病死率21.5%,多因素分析示年龄(OR 1.05,P=.007)、肾替代治疗(OR 3.56,P=.019)、真菌感染(OR 9.12,P=.0006)为独立死亡预测因素。
- 病原以肠杆菌科31%、金黄色葡萄球菌22%、铜绿假单胞菌19.3%最常见,真菌占10.5%,多微生物感染占35.6%。
- 38%为医院获得性感染,40.9%免疫抑制;咯血占21.7%,其中12%需支气管动脉栓塞。
- 经皮脓肿引流11.7%、手术12.7%,二者在多因素分析中均不是ICU死亡的独立预测因素。
- 作者认为需前瞻性研究聚焦一线抗菌治疗和感染源控制以改善并标准化管理。
适用人群与场景
- 法国ICU收治的肺脓肿成人患者,基于ICD-10编码纳入,2015至2022年共171例。
处置流程与药物剂量
- 经皮脓肿引流 performed in 11.7%,手术 performed in 12.7%,12%因咯血需支气管动脉栓塞。
- 作者认为需前瞻性研究聚焦一线抗菌治疗和感染源控制以改善并标准化管理。
红旗征与不能漏的情况
- 咯血 reported in 21.7%,其中12%需支气管动脉栓塞。
研究设计与关键结果
- 多中心回顾性观察研究,纳入171例ICU肺脓肿患者,78%男性,平均年龄56.5±16.4岁。
- 20.4%酒精滥用,25.2%慢性肺病(14% COPD),20.5%肿瘤史,40.9%免疫抑制,38%医院获得性感染。
- 症状:乏力或体重下降62%、发热50.3%、呼吸困难47.4%、咯血21.7%。
- 多微生物感染35.6%;病原:肠杆菌科31%、金黄色葡萄球菌22%、铜绿假单胞菌19.3%、真菌10.5%。
- 临床影像学模式集群与特定微生物学证据相关,可能指导经验性抗菌方案。
- ICU病死率21.5%;多因素logistic回归示年龄(OR 1.05 [1.02-1.91],P=.007)、ICU期间肾替代治疗(OR 3.56 [1.24-10.57],P=.019)、真菌感染(OR 9.12 [2.69-34.5],P=.0006)为独立死亡预测因素,引流或手术不是。
证据类型、等级与局限
- 研究类型:回顾性观察性多中心研究,基于ICD-10编码,2015至2022年法国。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需前瞻性研究聚焦一线抗菌治疗和感染源控制以改善并标准化管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Data are scarce regarding epidemiology and management of critically ill patients with lung abscesses.
RESEARCH QUESTION: What are the clinical and microbiological characteristics of critically ill patients with lung abscesses, how are they managed in the ICU, and what are the risk factors of in-ICU mortality?
STUDY DESIGN AND METHODS: This was a retrospective observational multicenter study, based on International Classification of Diseases, 10th Revision, codes, between 2015 and 2022 in France. In-ICU mortality-associated factors were determined by multivariate logistic regression.
RESULTS: We analyzed 171 ICU patients with pulmonary abscesses. Seventy-eight percent were male, with a mean age of 56.5 ± 16.4 years; 20.4% misused alcohol, 25.2% had a chronic lung disease (14% COPD), and 20.5% had a history of cancer. Overall, 40.9% were immunocompromised and 38% qualified for nosocomial infection. Presenting symptoms included fatigue or weight loss in 62%, fever (50.3%), and dyspnea (47.4%). Hemoptysis was reported in 21.7%. A polymicrobial infection was present in 35.6%. The most frequent pathogens were Enterobacteriaceae in 31%, Staphylococcus aureus in 22%, and Pseudomonas aeruginosa in 19.3%. Fungal infections were found in 10.5%. Several clusters of clinicoradiologic patterns were associated with specific microbiological documentation and could guide empiric antibiotic regimen. Percutaneous abscess drainage was performed in 11.7%; surgery was performed in 12.7%, and 12% required bronchial artery embolization for hemoptysis. In-ICU mortality was 21.5%, and age (OR: 1.05 [1.02-1.91], P = .007], renal replacement therapy during ICU stay (OR, 3.56 [1.24-10.57], P = .019), and fungal infection (OR, 9.12 [2.69-34.5], P = .0006) were independent predictors of mortality after multivariate logistic regression, and drainage or surgery were not.
INTERPRETATION: Pulmonary abscesses in the ICU are a rare but severe disease often resulting from a polymicrobial infection, with a high proportion of Enterobacteriaceae, S aureus, and P aeruginosa. Percutaneous drainage, surgery, or arterial embolization was required in more than one-third of cases. Further prospective studies focusing on first-line antimicrobial therapy and source control procedure are warranted to improve and standardize patient management.
参考来源
- Montméat V, Bonny V, Urbina T, et al. Epidemiology and Clinical Patterns of Lung Abscesses in ICU: A French Multicenter Retrospective Study. Chest. 2023. PMID: 37652296. doi:10.1016/j.chest.2023.08.020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。